These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 6167268)

  • 1. Protection of iron-catalysed the radical damage to DNA and lipids by copper (II) bleomycin.
    Gutteridge JM; Xiao Change F
    Biochem Biophys Res Commun; 1981 Apr; 99(4):1354-60. PubMed ID: 6167268
    [No Abstract]   [Full Text] [Related]  

  • 2. Chemical, biochemical, and cellular properties of copper and iron bleomycins.
    Solaiman D; Rao EA; Petering DH; Sealy RC; Antholine WE
    Int J Radiat Oncol Biol Phys; 1979 Sep; 5(9):1519-21. PubMed ID: 94054
    [No Abstract]   [Full Text] [Related]  

  • 3. Bleomycin-metal interaction: ferrous iron-initiated chemiluminescence.
    Trush MA; Mimnaugh EG; Siddik ZH; Gram TE
    Biochem Biophys Res Commun; 1983 Apr; 112(2):378-83. PubMed ID: 6189484
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Catalase enhances damage to DNA by bleomycin-iron(II): the role of hydroxyl radicals.
    Gutteridge JM; Beard AP; Quinlan GJ
    Biochem Int; 1985 Mar; 10(3):441-9. PubMed ID: 2409975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutathionyl hydroquinone: a potent pro-oxidant and a possible toxic metabolite of benzene.
    Rao GS
    Toxicology; 1996 Jan; 106(1-3):49-54. PubMed ID: 8571401
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enhancement of bleomycin-iron free radical damage to DNA by antioxidants and their inhibition of lipid peroxidation.
    Gutteridge JM; Fu XC
    FEBS Lett; 1981 Jan; 123(1):71-4. PubMed ID: 6162680
    [No Abstract]   [Full Text] [Related]  

  • 7. Bleomycin A2: a ferrous oxidase.
    Caspary WJ; Niziak C; Lanzo DA; Friedman R; Bachur NR
    Mol Pharmacol; 1979 Jul; 16(1):256-60. PubMed ID: 90330
    [No Abstract]   [Full Text] [Related]  

  • 8. Effects of iron, copper, cobalt, and their chelators on the cytotoxicity of bleomycin.
    Lin PS; Kwock L; Hefter K; Misslbeck G
    Cancer Res; 1983 Mar; 43(3):1049-53. PubMed ID: 6186368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bleomycin-induced trans lipid formation in cell membranes and in liposome models.
    Cort A; Ozben T; Sansone A; Barata-Vallejo S; Chatgilialoglu C; Ferreri C
    Org Biomol Chem; 2015 Jan; 13(4):1100-5. PubMed ID: 25417813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Measurement of hydroxyl radicals catalyzed in the immediate vicinity of DNA by metal-bleomycin complexes.
    Chakrabarti S; Makrigiorgos GM; O'Brien K; Bump E; Kassis AI
    Free Radic Biol Med; 1996; 20(6):777-83. PubMed ID: 8728024
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Inhibition of the Fenton reaction by the protein caeruloplasmin and other copper complexes. Assessment of ferroxidase and radical scavenging activities.
    Gutteridge JM
    Chem Biol Interact; 1985 Dec; 56(1):113-20. PubMed ID: 3000633
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bleomycin-iron damage to DNA with formation of 8-hydroxydeoxyguanosine and base propenals. Indications that xanthine oxidase generates superoxide from DNA degradation products.
    Gutteridge JM; West M; Eneff K; Floyd RA
    Free Radic Res Commun; 1990; 10(3):159-65. PubMed ID: 1697821
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cytotoxic effect of free bleomycin A5-iron (II) complex and its conjugates with concanavalin A, insulin and calcitonin on mouse thymocytes.
    Matkhanov IE; Galanova YuV ; Voschinnikov EI; Archakov AI
    Biochem Biophys Res Commun; 1993 Nov; 197(1):85-91. PubMed ID: 7504486
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Potentiation of bleomycin cytotoxicity in Saccharomyces cerevisiae.
    Moore CW
    Antimicrob Agents Chemother; 1994 Jul; 38(7):1615-9. PubMed ID: 7526783
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Ferrous iron-mediated enhancement of DNA damage and recovery potential in bleomycin-treated human cells.
    Smith PJ
    Biochem Pharmacol; 1987 Feb; 36(4):475-80. PubMed ID: 2435289
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Augmentation of bleomycin-induced DNA damage in intact cells.
    Moseley PL
    Am J Physiol; 1989 Nov; 257(5 Pt 1):C882-7. PubMed ID: 2480714
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Poduction of free radicals from phenol and tocopherol by bleomycin-iron(II) complex.
    Sugiura Y
    Biochem Biophys Res Commun; 1979 Mar; 87(2):649-53. PubMed ID: 87194
    [No Abstract]   [Full Text] [Related]  

  • 18. Mechanism of bleomycin action: in vitro studies.
    Burger RM; Peisach J; Horwitz SB
    Life Sci; 1981 Feb; 28(7):715-27. PubMed ID: 6164898
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron(II)-bleomycin. Biochemical and spectral properties in the presence of radical scavengers.
    Rodriguez LO; Hecht SM
    Biochem Biophys Res Commun; 1982 Feb; 104(4):1470-6. PubMed ID: 6176244
    [No Abstract]   [Full Text] [Related]  

  • 20. Orientation of iron bleomycin and porphyrin complexes on DNA fibers.
    Chikira M; Iiyama T; Sakamoto K; Antholine WE; Petering DH
    Inorg Chem; 2000 Apr; 39(8):1779-86. PubMed ID: 12526568
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.